Home
ACHL
ACHL News

Latest Achilles Therapeutics plc (ACHL) News on February 23, 2025

February 2025's Promising Penny Stocks On US Exchanges

Simply Wall St.

18 days ago

February 2025's Promising Penny Stocks On US Exchanges

Achilles Therapeutics sells technology assets to AstraZeneca for $12M

TipRanks

2 months ago

Achilles Therapeutics sells technology assets to AstraZeneca for $12M

MT Newswires

2 months ago

Achilles Therapeutics Sells Technology Assets to AstraZeneca for $12 Million, Concluding Strategic Review; Shares Up

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

GlobeNewswire

2 months ago

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

US Penny Stocks To Watch In November 2024

Simply Wall St.

3 months ago

US Penny Stocks To Watch In November 2024

Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market

GlobeNewswire

3 months ago

Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market

Achilles Therapeutics Reports Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Achilles Therapeutics Reports Third Quarter 2024 Financial Results

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?

Zacks

5 months ago

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?

MT Newswires

5 months ago

Achilles Therapeutics Discontinues cNeT Program and Closes Early-to-Mid Stage Studies For Cancer Treatment

Achilles Therapeutics Announces Strategic Update

GlobeNewswire

5 months ago

Achilles Therapeutics Announces Strategic Update

Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?

Simply Wall St.

6 months ago

Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates

GlobeNewswire

6 months ago

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

PR Newswire

9 months ago

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

3 Major Product Releases at 3Shape Discover Event

PR Newswire

9 months ago

3 Major Product Releases at 3Shape Discover Event

Business Wire

9 months ago

Net Asset Value(s)

Irish, Czechs hold EU vote after Dutch far-right gains

AFP

9 months ago

Irish, Czechs hold EU vote after Dutch far-right gains

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

Motley Fool

9 months ago

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

GlobeNewswire

9 months ago

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

GlobeNewswire

9 months ago

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

PR Newswire

9 months ago

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

MT Newswires

9 months ago

Achilles Therapeutics Collaborating With Arcturus Therapeutics to Evaluate mRNA Personalized Cancer Vaccines

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

GlobeNewswire

9 months ago

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

GlobeNewswire

9 months ago

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

9 months ago

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

GlobeNewswire

a year ago

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

GlobeNewswire

a year ago

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?

Simply Wall St.

a year ago

Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?

Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?

Zacks

a year ago

Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

GlobeNewswire

a year ago

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

HMN Financial Inc. Reports Decreased Earnings in Q4 and Full Year 2023, Declares Dividend

GuruFocus.com

a year ago

HMN Financial Inc. Reports Decreased Earnings in Q4 and Full Year 2023, Declares Dividend

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?

DHI Group, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Business Wire

a year ago

DHI Group, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

AGM Group Holdings First Half 2023 Earnings: EPS: US$0.66 (vs US$0.68 in 1H 2022)

Simply Wall St.

a year ago

AGM Group Holdings First Half 2023 Earnings: EPS: US$0.66 (vs US$0.68 in 1H 2022)

Electrovaya Begins Shipping Infinity-HV Battery Systems

ACCESSWIRE

a year ago

Electrovaya Begins Shipping Infinity-HV Battery Systems

Business Wire

a year ago

Bragg Gaming Supplies Online Casino Game Aggregation for Superbet in Brazil

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

GlobeNewswire

a year ago

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

3 High-Potential Penny Stocks That Can Be 5-Baggers by 2025

InvestorPlace

a year ago

3 High-Potential Penny Stocks That Can Be 5-Baggers by 2025

Analysts Expect Breakeven For Bragg Gaming Group Inc. (TSE:BRAG) Before Long

Simply Wall St.

a year ago

Analysts Expect Breakeven For Bragg Gaming Group Inc. (TSE:BRAG) Before Long

Zentek Announces Grant of Stock Options

ACCESSWIRE

a year ago

Zentek Announces Grant of Stock Options

SKYX Announces Product Collaboration With World Leading Lighting Company Kichler for the Builder Segment as SKYX Continues to Enhance its Market Penetration

ACCESSWIRE

a year ago

SKYX Announces Product Collaboration With World Leading Lighting Company Kichler for the Builder Segment as SKYX Continues to Enhance its Market Penetration

Business Wire

a year ago

Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024

Business Wire

a year ago

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

GlobeNewswire

a year ago

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

a year ago

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

a.k.a. Brands Holding Corp. Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

a.k.a. Brands Holding Corp. Reports Third Quarter 2023 Financial Results

Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript

Several Insiders Invested In Cyclo Therapeutics Flagging Positive News

Simply Wall St.

a year ago

Several Insiders Invested In Cyclo Therapeutics Flagging Positive News

Thomson Reuters StreetEvents

a year ago

Q3 2023 Natural Health Trends Corp Earnings Call

Share on Social Networks: